Miller, MS CJ, Dart, MD RC, Katz, MD, MS NP, Webster, MD, FACPM, FASAM LR. Insights and issues from FDA Advisory Committee meetings on abuse-deterrent opioids. J of Opioid Management [Internet]. 2017 Dec. 7 [cited 2024 Nov. 24];13(6):379-8. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/764